AMZN
Amazon.com, Inc.
AMZN has the edge over DBI overall, supported by stronger valuation and lower modeled downside.
DBI
Designer Brands Inc.
DBI trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
DBI's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over DBI in the historical PE scenario, which offers more potential upside but is not a forecast.
DBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.9x | $1.47 | -77% |
| Fair | 7x | $2.10 | -67% |
| Forward | 12x | $6.43 | — |
| Current | 21x | $6.43 | — |
| Expensive | 25x | $7.44 | +16% |
Historical ranges are pointers, not guarantees.
DBI's PE is in its expensive range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
DBI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect DBI's earnings to grow, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
DBI has the stronger earnings trend. Trailing diluted EPS is up 75% for AMZN versus DBI up 1,400%.
DBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.55 | +82% |
| Q4 2024 | $0.05 | -97% |
| Q3 2024 | -$0.02 | -101% |
| Q2 2024 | $0.30 | -86% |
| Q1 2024 | $0.46 | -80% |
| Q4 2023 | $1.55 | -14% |
| Q3 2023 | $2.03 | -7.3% |
| Q2 2023 | $2.09 | -1.4% |
| Q1 2023 | $2.26 | +13% |
DBI has returned to profit: it earned $0.30 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over DBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over DBI on profitability, with a higher operating margin.
DBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $730.6M | -1.2% |
| Q2 2026 | $696.4M | +1.4% |
| Q1 2026 | $713.6M | 0% |
| Q4 2025 | $752.4M | -3.2% |
| Q3 2025 | $739.8M | -4.2% |
| Q2 2025 | $686.9M | -8% |
| Q1 2025 | $713.6M | -5.4% |
| Q4 2024 | $777.2M | -1.2% |
DBI's revenue fell from its 2019 peak and has held roughly level since: $731M last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.5% | +3.9 points |
| Q2 2026 | 2.7% | +3.8 points |
| Q1 2026 | -2% | +1.6 points |
| Q4 2025 | 5.7% | +2.7 points |
| Q3 2025 | 3.6% | -0.1 points |
| Q2 2025 | -1.1% | -2.3 points |
| Q1 2025 | -3.6% | +1.1 points |
| Q4 2024 | 2.9% | -0.6 points |
DBI's operating margin was 7.5% last quarter, up 3.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.9M | +386% |
| Q2 2026 | -$31.9M | -$4.3M |
| Q1 2026 | $36.4M | -37% |
| Q4 2025 | $57.5M | +$76.7M |
| Q3 2025 | $11.9M | -57% |
| Q2 2025 | -$27.6M | +$8M |
| Q1 2025 | $58.1M | +$110.9M |
| Q4 2024 | -$19.2M | -138% |
DBI has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over DBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +54K shares |
| 1 year | +13% | +6.2M shares |
| 3 years | -17% | -11.1M shares |
| 5 years | -27% | -21M shares |
| Available history | -23% | -17M shares |
DBI has 56M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $50.6M |
| Q1 2024 | $54,000 |
| Q4 2023 | $79.7M |
| Q3 2023 | $22.4M |
| Q2 2023 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over DBI on leverage, with a lower net debt burden relative to earnings.
DBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 4.3x | High |
| Q3 2025 | 6.0x | High |
| Q2 2025 | 5.8x | High |
| Q1 2025 | 4.5x | High |
| Q4 2024 | 5.4x | High |
DBI's net debt is about 2.3 years of its operating earnings (EBITDA), down from 6.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 71.1 | Neutral |
DBI's weekly RSI is 53 (neutral) and its Stochastic is 71 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DBI PE vs Consumer Cyclical Sector
| Metric | DBI | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 75 | 47 | 28 pts above |
DBI has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DBI on trend strength, trading above more of its moving averages.
DBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.25 | 2.9% above |
| 20 week MA | $5.96 | 7.9% above |
| 50 week MA | $6.55 | 1.8% below |
| 100 week MA | $5.18 | 24% above |
| 200 week MA | $7.00 | 8.1% below |
DBI's trend is mixed: it's above three of its five weekly moving averages, and 8.1% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DBI on returns for 2026, with the stronger performance.
DBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.6 | $7.14 | -54% |
| 2021 | $7.14 | $14.5 | +103% |
| 2022 | $14.5 | $9.82 | -32% |
| 2023 | $9.82 | $8.85 | -9.9% |
| 2024 | $8.85 | $5.40 | -39% |
| 2025 | $5.40 | $7.78 | +44% |
| 2026 YTD | $7.78 | $6.43 | -17% |
DBI's yearly returns have swung widely, from +103% in 2021 to −54% in 2020. It's down 17% so far in 2026.